Dimensional Fund Advisors LP Viking Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 111,156 shares of VKTX stock, worth $4.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

111,156

Previous 46,890 137.06%

Holding current value

$4.7 Million

Previous $2.49 Million 183.18%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$49.84 - $70.47 $3.2 Million - $4.53 Million	64,266 Added 137.06%	111,156 $7.04 Million
Q2 2024 Aug 09, 2024	SELL	$47.39 - $80.2 $12,416 - $21,012	-262 Reduced 0.56%	46,890 $2.49 Million
Q1 2024 May 10, 2024	SELL	$17.4 - $94.5 $260,669 - $1.42 Million	-14,981 Reduced 24.11%	47,152 $3.87 Million
Q4 2023 Feb 07, 2024	SELL	$9.24 - $19.64 $3.37 Million - $7.16 Million	-364,631 Reduced 85.44%	62,133 $1.16 Million
Q3 2023 Nov 09, 2023	SELL	$10.92 - $16.0 $1.17 Million - $1.72 Million	-107,568 Reduced 20.13%	426,764 $4.72 Million
Q1 2023 May 12, 2023	SELL	$8.08 - $17.33 $2.54 Million - $5.45 Million	-314,395 Reduced 37.04%	534,332 $8.9 Million
Q4 2022 Feb 09, 2023	SELL	$2.72 - $9.4 $177,441 - $613,218	-65,236 Reduced 7.14%	848,727 $7.98 Million
Q3 2022 Nov 10, 2022	SELL	$2.55 - $3.89 $943,403 - $1.44 Million	-369,962 Reduced 28.81%	913,963 $2.49 Million
Q2 2022 Aug 12, 2022	SELL	$2.11 - $3.15 $193,191 - $288,414	-91,560 Reduced 6.66%	1,283,925 $3.71 Million
Q1 2022 May 13, 2022	BUY	$3.0 - $4.88 $937,131 - $1.52 Million	312,377 Added 29.38%	1,375,485 $4.13 Million
Q4 2021 Feb 09, 2022	BUY	$4.6 - $6.72 $1.36 Million - $1.99 Million	296,385 Added 38.66%	1,063,108 $4.89 Million
Q3 2021 Nov 12, 2021	BUY	$5.58 - $7.04 $2.4 Million - $3.03 Million	430,845 Added 128.27%	766,723 $4.82 Million
Q2 2021 Aug 12, 2021	BUY	$5.19 - $6.73 $121,830 - $157,980	23,474 Added 7.51%	335,878 $2.01 Million
Q1 2021 May 14, 2021	BUY	$5.74 - $9.67 $654,618 - $1.1 Million	114,045 Added 57.49%	312,404 $1.98 Million
Q4 2020 Feb 25, 2021	BUY	$5.3 - $6.71 $1.05 Million - $1.33 Million	198,359 New	198,359 $1.12 Million

Others Institutions Holding VKTX

# of Institutions

473

Shares Held

65.6M

Call Options Held

5.72M

Put Options Held

3.39M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $3.24B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Viking Therapeutics, Inc. Transaction History